Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Ryder System Inc. Executive Vice President and Chief Information Officer Ravindran Rajeev sold 2,696 shares on February 19, 2026, totaling about $597,454 in two trades. The sale occurred as Ryder's stock traded near its 52-week high and followed a quarterly report that beat EPS expectations but missed revenue estimates.
Coupang's major data breach and ensuing investigations have already cost the stock, but the real financial and operational consequences - fines, lawsuits, lost customer trust, and higher compliance costs - are likely to play out over multiple quarters. With a market value near $34.3B, modest free cash flow and rich profitability multiples, the path…
Patrick Plewman, senior vice president for Diagnostic Services at Quest Diagnostics (DGX), reported multiple transactions in a Form 4 filing including the sale of 958 shares on Feb. 19 for about $196,227 and prior disposals on Feb. 18 to cover tax obligations totaling $111,890. The filings also show a restricted stock unit award of 1,952 shares wit…
Tempus AI, Inc. CEO and Chairman Eric P. Lefkofsky sold roughly $10.5 million of Class A common stock on February 19, 2026, under a pre-established 10b5-1 plan, and on February 20 received 263,430 fully vested restricted stock units. The transactions included multiple tranches sold at prices between $58.31 and $59.70 and a separate sale to cover ta…
JFrog shares dropped more than 20% after Anthropic unveiled Claude Code Security, prompting investor concern that AI-native tools could erode demand for package-level controls. Raymond James kept an Outperform rating, arguing the sell-off exaggerates the near-term risk. The firm points to JFrog’s artifact-layer control point, contracted security re…
Septerna President and COO Elizabeth Bhatt sold 4,000 shares on February 18, 2026, totaling $115,860 under a Rule 10b5-1 plan and exercised options to acquire 4,000 shares at $6.81 per share the same day. The company continues to advance its SEP-631 program and has drawn renewed analyst attention and senior legal leadership additions.
Fold Holdings Chief Financial Officer Wolfe Repass sold 21,857 shares on February 19, 2026 to satisfy tax-withholding obligations tied to restricted stock units, while converting a larger block of RSUs into common stock across February 18-19. The moves unfold as the company outlines a simplified bitcoin services plan, secures inclusion in the Russe…
Erik Bradbury, DraftKings' Chief Accounting Officer, sold 7,268 Class A shares on February 19, 2026, for $163,530 under a pre-arranged Rule 10b5-1 plan. The sale occurred as DraftKings shares trade close to their 52-week low and follow a quarter that topped expectations but was accompanied by conservative guidance that has prompted several analysts…
The Federal Energy Regulatory Commission has approved Blackstone Infrastructure's acquisition of TXNM Energy, concluding the transaction is consistent with the public interest and dismissing concerns tied to private equity ownership. With key federal and state clearances in place, remaining approvals from the Nuclear Regulatory Commission and the N…
Oregon Community Foundation sold 46,750 shares of Jewett-Cameron Trading Co. Ltd. (JCTC) common stock on February 19 and 20, 2026, in three transactions totaling $83,766. After the disposals the foundation holds 785,959 shares. The stock is trading close to its 52-week low and recently posted disappointing fourth-quarter 2025 results, while an inde…
Vanda Pharmaceuticals announced FDA approval of BYSANTI (milsaperidone) for treatment of Bipolar I manic episodes and schizophrenia symptoms in adults, marking the company's second approval in under two months and triggering a 44% after-hours jump in its stock. The drug is classified as a New Chemical Entity with patent protection through 2044 and …
Talphera Chief Financial Officer Raffi Asadorian reported purchasing 45,000 shares on February 12 at $0.8123 per share for a total of $36,553, while surrendering 3,891 shares to cover tax obligations and receiving options to buy 260,000 shares exercisable at $0.8123 and expiring February 11, 2036. The company’s stock was trading around $0.78 and ca…
Director Jack L. Wyszomierski sold 99,574 shares of Exelixis common stock on February 18, 2026, generating roughly $4.38 million in proceeds, and on the same day exercised options to buy 20,634 shares at $19.77 each. The transactions leave him with 279,942 shares held directly. Exelixis reported fourth-quarter 2025 earnings that beat EPS expectatio…
Talphera, Inc. (NASDAQ:TLPH) Chief Medical Officer Aslam Shakil purchased 35,000 common shares on February 12, 2026, at $0.8123 per share for a total of $28,430, boosting his direct holdings to 83,178 shares. The same day he received an option for 205,000 shares exercisable at $0.8123 that vests over four years and expires in 2036. InvestingPro ana…
Talphera, Inc. Chief Engineering Officer Dasu Badri N. purchased 35,000 shares at $0.8123 per share, a transaction valued at $28,430, according to a recent SEC Form 4. The filing also records a small disposal of shares to satisfy tax withholding and a grant of 200,000 stock options that vest over four years beginning in February 2027. The company's…
SoFi Technologies executive Kelli Keough sold 9,755 shares on February 20, 2026, for $184,117 under a pre-established Rule 10b5-1 plan. The transaction occurred as SoFi shares trade near $19, a share price down sharply year-to-date and materially below the 52-week peak. Analysts have issued a mix of upgrades and target adjustments, reflecting diver…
Vincent J. Angotti, Chief Executive Officer of Talphera, Inc. (TLPH), reported a purchase of 105,364 common shares on February 12, 2026, at $0.8123 per share for a total of $85,587. The filing also shows smaller disposals to cover tax obligations and a substantial option grant tied to the same exercise price. After the transactions, Angotti directl…
Rapid Micro Biosystems Chief Operating Officer John J. Addington Wilson sold 5,403 Class A common shares on February 20, 2026, at $3.923 per share to meet tax liabilities tied to vested restricted stock units. After the transaction Wilson holds 326,365 shares. The stock has risen 45% over the last six months even as InvestingPro flags the shares as…
U.S. Trade Representative Jamieson Greer announced on Friday that his office will launch multiple investigations under Section 301 of the Trade Act of 1974. The reviews are expected to span most of the United States' major trading partners and to examine issues including pharmaceutical product pricing, industrial excess capacity, forced labor, and …
Kathryn G. Simpson, Northrop Grumman vice president and general counsel, disposed of 194 shares on February 19, 2026, in a trade governed by a pre-set Rule 10b5-1 plan. The company also reported fourth-quarter 2025 results above consensus, received a $198 million contract for E-2D Advanced Hawkeye power amplifier module spares, saw its dividend dec…
Align Technology EVP and CFO John Morici sold 7,969 shares on February 18, 2026, generating roughly $1.5 million. The transaction, disclosed in a Form 4 filing with the Securities and Exchange Commission, took place at prices between $189.05 and $189.65. The company also reported fourth-quarter 2025 results that beat estimates, prompting several an…
Matthew C. Busch, Amgen’s vice president of finance and chief accounting officer, sold 1,000 shares of common stock on February 19, 2026, for $375,790. The company’s recent quarterly results and fiscal 2026 guidance have prompted divergent analyst reactions, producing a broad spectrum of price targets and ratings for the stock.
Weyerhaeuser director O’Rourke James Calvin purchased 4,000 shares on Feb. 20, 2026, increasing his direct stake to 28,661.379 shares. The transaction totaled $101,400. The company reported Q4 2025 earnings that beat estimates on EPS but narrowly missed revenue expectations, and DA Davidson maintained a Buy rating while raising its FY2026 EBITDA fo…
Mitsui Sumitomo Insurance Co., LTD, a ten-percent owner of BERKLEY W R CORP (NASDAQ:WRB), acquired $35.7 million of Berkley common stock across three transactions executed February 19-20, 2026 under a Rule 10b5-1 plan. The purchases increased Mitsui Sumitomo's direct stake to 57,668,620 shares. W. R. Berkley recently reported Q4 2025 revenue above …
The U.S. Supreme Court has adjudicated numerous challenges to actions taken by President Donald Trump and his administration since his inauguration in January 2025. Cases before the justices have ranged from trade policy and the independence of the Federal Reserve to immigration enforcement, the removal of agency officials, large-scale federal layo…
